PROK 2.62 ▼ -3.68% Live Trading Data - Stocknear

ProKidney Corp.

NASDAQ: PROK · Real-Time Price · USD
2.62
-0.10 (-3.68%)
At close: Sep 25, 2025, 3:59 PM
2.66
1.53%
After-hours: Sep 25, 2025, 05:22 PM EDT
-3.68%
Bid 2.55
Market Cap 783.37M
Revenue (ttm) 527K
Net Income (ttm) -72.47M
EPS (ttm) -0.56
PE Ratio (ttm) -4.68
Forward PE -4.98
Analyst Strong Buy
Dividends n/a
Ask 2.68
Volume 772,507
Avg. Volume (20D) 13,792,353
Open 2.67
Previous Close 2.72
Day's Range 2.57 - 2.69
52-Week Range 0.46 - 7.13
Beta 1.79
Ex-Dividend Date n/a

About PROK

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PROK
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PROK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
ProKidney Corp. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-8.67%
PROK stock has given up its prior gain. ProKidney ... Unlock content with Pro Subscription
2 months ago
-8.67%
ProKidney shares are trading higher after the company announced it is aligned with the FDA regarding the accelerated approval and pathway for Rilparencel.